FDA Orange Book · active-ingredient family
Fluoxymesterone
Fluoxymesterone is approved as 2 brand and 6 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:HALOTESTIN · NDA 010611
2
Brand (NDA)
6
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| HALOTESTIN×3 | PHARMACIA AND UPJOHN | NDA 010611 | — | Approved Prior to Jan 1, 1982 | |
| ORA-TESTRYL×2 | BRISTOL MYERS SQUIBB | NDA 011359 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (6)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| FLUOXYMESTERONE | WATSON LABS | ANDA 088260 | — | Dec 06, 1983 | |
| FLUOXYMESTERONE | WATSON LABS | ANDA 088265 | — | Dec 06, 1983 | |
| FLUOXYMESTERONE | WATSON LABS | ANDA 088309 | — | Dec 06, 1983 | |
| FLUOXYMESTERONE | UPSHER SMITH LABS | ANDA 088342 | — | Oct 21, 1983 | |
| FLUOXYMESTERONE | VALEANT PHARM INTL | ANDA 088221 | — | May 05, 1983 | |
| ANDROID-F | VALEANT PHARM INTL | ANDA 087196 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Fluoxymesterone — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

